skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: assunto: Life Sciences & Biomedicine remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Obinutuzumab (GA101) compared to rituximab significantly enhances cell death and antibody‐dependent cytotoxicity and improves overall survival against CD20+ rituximab‐sensitive/‐resistant Burkitt lymphoma (BL) and precursor B‐acute lymphoblastic leukaemia (pre‐B‐ALL): potential targeted therapy in patients with poor risk CD20+ BL and pre‐B‐ALL
Obinutuzumab (GA101) compared to rituximab significantly enhances cell death and antibody‐dependent cytotoxicity and improves overall survival against CD20+ rituximab‐sensitive/‐resistant Burkitt lymphoma (BL) and precursor B‐acute lymphoblastic leukaemia (pre‐B‐ALL): potential targeted therapy in patients with poor risk CD20+ BL and pre‐B‐ALL
Material Type:
Artigo 		Adicionar ao Meu Espaço

Obinutuzumab (GA101) compared to rituximab significantly enhances cell death and antibody‐dependent cytotoxicity and improves overall survival against CD20+ rituximab‐sensitive/‐resistant Burkitt lymphoma (BL) and precursor B‐acute lymphoblastic leukaemia (pre‐B‐ALL): potential targeted therapy in patients with poor risk CD20+ BL and pre‐B‐ALL

Awasthi, Aradhana ; Ayello, Janet ; Van de Ven, Carmella ; Elmacken, Mona ; Sabulski, Anthony ; Barth, Matthew J. ; Czuczman, Myron S. ; Islam, Humayun ; Klein, Christian ; Cairo, Mitchell S.

British journal of haematology, 2015-12, Vol.171 (5), p.763-775 [Periódico revisado por pares]

England

Texto completo disponível

Citações Citado por
2
Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience
Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience
Material Type:
Artigo 		Adicionar ao Meu Espaço

Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience

Salles, Gilles ; Barrett, Martin ; Foà, Robin ; Maurer, Joerg ; O’Brien, Susan ; Valente, Nancy ; Wenger, Michael ; Maloney, David G.

Advances in therapy, 2017-10, Vol.34 (10), p.2232-2273 [Periódico revisado por pares]

Cheshire: Springer Healthcare

Texto completo disponível

Citações Citado por
3
Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2)
Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2)

Charles, Pierre ; Terrier, Benjamin ; Perrodeau, Élodie ; Cohen, Pascal ; Faguer, Stanislas ; Huart, Antoine ; Hamidou, Mohamed ; Agard, Christian ; Bonnotte, Bernard ; Samson, Maxime ; Karras, Alexandre ; Jourde-Chiche, Noémie ; Lifermann, François ; Gobert, Pierre ; Hanrotel-Saliou, Catherine ; Godmer, Pascal ; Martin-Silva, Nicolas ; Pugnet, Grégory ; Matignon, Marie ; Aumaitre, Olivier ; Viallard, Jean-François ; Maurier, François ; Meaux-Ruault, Nadine ; Rivière, Sophie ; Sibilia, Jean ; Puéchal, Xavier ; Ravaud, Philippe ; Mouthon, Luc ; Guillevin, Loïc

Annals of the rheumatic diseases, 2018-08, Vol.77 (8), p.1143-1149 [Periódico revisado por pares]

England: BMJ Publishing Group LTD

Texto completo disponível

Citações Citado por
4
Copanlisib plus rituximab versus placebo plus rituximab in patients with relapsed indolent non-Hodgkin lymphoma (CHRONOS-3): a double-blind, randomised, placebo-controlled, phase 3 trial
Copanlisib plus rituximab versus placebo plus rituximab in patients with relapsed indolent non-Hodgkin lymphoma (CHRONOS-3): a double-blind, randomised, placebo-controlled, phase 3 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Copanlisib plus rituximab versus placebo plus rituximab in patients with relapsed indolent non-Hodgkin lymphoma (CHRONOS-3): a double-blind, randomised, placebo-controlled, phase 3 trial

Matasar, Matthew J ; Capra, Marcelo ; Özcan, Muhit ; Lv, Fangfang ; Li, Wei ; Yañez, Eduardo ; Sapunarova, Katya ; Lin, Tongyu ; Jin, Jie ; Jurczak, Wojciech ; Hamed, Aryan ; Wang, Ming-Chung ; Baker, Ross ; Bondarenko, Igor ; Zhang, Qingyuan ; Feng, Jifeng ; Geissler, Klaus ; Lazaroiu, Mihaela ; Saydam, Guray ; Szomor, Árpád ; Bouabdallah, Krimo ; Galiulin, Rinat ; Uchida, Toshiki ; Soler, Lidia Mongay ; Cao, Anjun ; Hiemeyer, Florian ; Mehra, Aruna ; Childs, Barrett H ; Shi, Yuankai ; Zinzani, Pier Luigi

The lancet oncology, 2021-05, Vol.22 (5), p.678-689 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
5
A tale of two antibodies: obinutuzumab versus rituximab
A tale of two antibodies: obinutuzumab versus rituximab
Material Type:
Artigo 		Adicionar ao Meu Espaço

A tale of two antibodies: obinutuzumab versus rituximab

Freeman, Ciara L. ; Sehn, Laurie H.

British journal of haematology, 2018-07, Vol.182 (1), p.29-45 [Periódico revisado por pares]

England: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
6
Liver Immune Profiling Reveals Pathogenesis and Therapeutics for Biliary Atresia
Liver Immune Profiling Reveals Pathogenesis and Therapeutics for Biliary Atresia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Liver Immune Profiling Reveals Pathogenesis and Therapeutics for Biliary Atresia

Wang, Jun ; Xu, Yanhui ; Chen, Zhanghua ; Liang, Jiankun ; Lin, Zefeng ; Liang, Huiying ; Xu, Yiping ; Wu, Qi ; Guo, Xuanjie ; Nie, Junli ; Lu, Bingtai ; Huang, Bing ; Xian, Huifang ; Wang, Xiaohui ; Wu, Qiang ; Zeng, Jixiao ; Chai, Chengwei ; Zhang, Meixue ; Lin, Yuzhen ; Zhang, Li ; Zhao, Shanmeizi ; Tong, Yanlu ; Zeng, Liang ; Gu, Xiaoqiong ; Chen, Zhuang-gui ; Yi, Shuhong ; Zhang, Tong ; Delfouneso, David ; Zhang, Yan ; Nutt, Stephen L. ; Lew, Andrew M. ; Lu, Liwei ; Bai, Fan ; Xia, Huimin ; Wen, Zhe ; Zhang, Yuxia

Cell, 2020-12, Vol.183 (7), p.1867-1883.e26 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
7
Optimization of rituximab for the treatment of DLBCL: increasing the dose for elderly male patients
Optimization of rituximab for the treatment of DLBCL: increasing the dose for elderly male patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

Optimization of rituximab for the treatment of DLBCL: increasing the dose for elderly male patients

Pfreundschuh, Michael ; Murawski, Niels ; Zeynalova, Samira ; Ziepert, Marita ; Loeffler, M. ; Hänel, Matthias ; Dierlamm, Judith ; Keller, Ulrich ; Dreyling, Martin ; Truemper, Lorenz ; Frickhofen, Norbert ; Hünerlitürkoglu, Ali‐Nuri ; Schmitz, Norbert ; Pöschel, Viola ; Rixecker, Tanja ; Berdel, Christian ; Rübe, Christian ; Held, Gerhard ; Zwick, Carsten

British journal of haematology, 2017-11, Vol.179 (3), p.410-420 [Periódico revisado por pares]

England: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
8
Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma
Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma

Tilly, Hervé ; Morschhauser, Franck ; Sehn, Laurie H ; Friedberg, Jonathan W ; Trněný, Marek ; Sharman, Jeff P ; Herbaux, Charles ; Burke, John M ; Matasar, Matthew ; Rai, Shinya ; Izutsu, Koji ; Mehta-Shah, Neha ; Oberic, Lucie ; Chauchet, Adrien ; Jurczak, Wojciech ; Song, Yuqin ; Greil, Richard ; Mykhalska, Larysa ; Bergua-Burgués, Juan M ; Cheung, Matthew C ; Pinto, Antonio ; Shin, Ho-Jin ; Hapgood, Greg ; Munhoz, Eduardo ; Abrisqueta, Pau ; Gau, Jyh-Pyng ; Hirata, Jamie ; Jiang, Yanwen ; Yan, Mark ; Lee, Calvin ; Flowers, Christopher R ; Salles, Gilles

The New England journal of medicine, 2022-01, Vol.386 (4), p.351-363 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
9
Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy
Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy

Fervenza, Fernando C ; Appel, Gerald B ; Barbour, Sean J ; Rovin, Brad H ; Lafayette, Richard A ; Aslam, Nabeel ; Jefferson, Jonathan A ; Gipson, Patrick E ; Rizk, Dana V ; Sedor, John R ; Simon, James F ; McCarthy, Ellen T ; Brenchley, Paul ; Sethi, Sanjeev ; Avila-Casado, Carmen ; Beanlands, Heather ; Lieske, John C ; Philibert, David ; Li, Tingting ; Thomas, Lesley F ; Green, Dolly F ; Juncos, Luis A ; Beara-Lasic, Lada ; Blumenthal, Samuel S ; Sussman, Amy N ; Erickson, Stephen B ; Hladunewich, Michelle ; Canetta, Pietro A ; Hebert, Lee A ; Leung, Nelson ; Radhakrishnan, Jay ; Reich, Heather N ; Parikh, Samir V ; Gipson, Debbie S ; Lee, Dominic K ; da Costa, Bruno R ; Jüni, Peter ; Cattran, Daniel C

The New England journal of medicine, 2019-07, Vol.381 (1), p.36-46 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
10
CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s Lymphoma
CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s Lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s Lymphoma

Advani, Ranjana ; Flinn, Ian ; Popplewell, Leslie ; Forero, Andres ; Bartlett, Nancy L ; Ghosh, Nilanjan ; Kline, Justin ; Roschewski, Mark ; LaCasce, Ann ; Collins, Graham P ; Tran, Thu ; Lynn, Judith ; Chen, James Y ; Volkmer, Jens-Peter ; Agoram, Balaji ; Huang, Jie ; Majeti, Ravindra ; Weissman, Irving L ; Takimoto, Chris H ; Chao, Mark P ; Smith, Sonali M

The New England journal of medicine, 2018-11, Vol.379 (18), p.1711-1721 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (17.739)
  2. Revistas revisadas por pares (17.735)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (18.615)
  2. Book Chapters  (54)
  3. magazinearticle  (2)
  4. Anais de Congresso  (1)
  5. Livros  (1)
  6. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de2001  (135)
  2. 2001Até2005  (1.125)
  3. 2006Até2010  (3.404)
  4. 2011Até2016  (5.704)
  5. Após 2016  (8.314)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (18.302)
  2. Japonês  (2.063)
  3. Francês  (173)
  4. Espanhol  (149)
  5. Alemão  (118)
  6. Português  (51)
  7. Russo  (42)
  8. Italiano  (30)
  9. Norueguês  (13)
  10. Húngaro  (9)
  11. Turco  (5)
  12. Polonês  (4)
  13. Serbian  (2)
  14. Coreano  (2)
  15. Islândico  (2)
  16. Tcheco  (1)
  17. Catalão  (1)
  18. Chinês  (1)
  19. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.